Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: TSH-stimulated hepatocyte exosomes modulate liver-adipose triglyceride accumulation via the TGF-β1/ATGL axis in mice

Fig. 2

ExosomesTSH enhance lipid accumulation in 3T3-L1 adipocytes via the TSH/TSHR pathway. (A-D) Oil Red O staining (A), Lipid droplet count (B), Quantification of triglyceride content (C), Quantification of FFA content (D) and Measurement of glycerol release (E) in 3T3-L1 adipocytes treated with exosomesTSH or exosomescon. (F-J) Oil Red O staining (F), Lipid droplet count (G), Quantification of triglyceride content (H), Quantification of FFA content (I) and Measurement of glycerol release (J) in 3T3-L1 adipocytes treated with exosomessi−Tshr and exosomessi−ctrl. Statistical significance: ** P < 0.01, *P < 0.05

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X